PTC Therapeutics to Participate in Upcoming Investor Conferences
PTC Therapeutics (PTCT) announced that its executives will speak at the Jefferies and Citi global healthcare investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PTC Therapeutics (PTCT) announced that its executives will speak at the Jefferies and Citi global healthcare investor conferences.
The Jefferies presentation is scheduled for Nov. 16 at 11 a.m. GMT/6 a.m. ET; Citi's is Dec. 1 at 9:40 a.m. ET. Both presentations will be webcast live through the company's investor website and archived for 30 days afterward.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Jefferies Global Healthcare Conference
Monday, Nov. 16 at 11 a.m. GMT/6 a.m. ET
Citi 2026 Global Healthcare Conference
Tuesday, Dec. 1 at 9:40 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of the PTC Therapeutics website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Facebook and Instagram.
For more information, please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-in-upcoming-investor-conferences-302925133.html
SOURCE PTC Therapeutics, Inc.